Kola, Susanna

English

University of Huddersfield Repository

University of Huddersfield RepositoryKola, SusannaAnxiety and the Colposcopy Experience Original CitationKola, Susanna (2007) Anxiety and the Colposcopy Experience. In: Invited public presentation on behalf of the Department of Obstetrics & Gynaecology, University Hostpital Galway, 29th November 2007, University Hospital Galway. (Unpublished)This version is available at http://eprints.hud.ac.uk/9782/The University Repository is a digital collection of the research output of theUniversity, available on Open Access. Copyright and Moral Rights for the itemson this site are retained by the individual author and/or other copyright owners.Users may access full items free of charge; copies of full text items generallycan be reproduced, displayed or performed and given to third parties in anyformat or medium for personal research or study, educational or not-for-profitpurposes without prior permission or charge, provided:• The authors, title and full bibliographic details is credited in any copy;• A hyperlink and/or URL is included for the original metadata page; and• The content is not changed in any way.For more information, including our policy and submission procedure, pleasecontact the Repository Team at: E.mailbox@hud.ac.uk.http://eprints.hud.ac.uk/10/2007Cervarix1088 Galway Healthcare Professionals call on women to talk to their GP or practice nurse about Cervical Cancer Prevention   Thursday, 29th November – Speaking at a public meeting at the Westwood Hotel, healthcare professionals encouraged women to get proactive and speak to their GP or practice nurse about their cervical health. Despite the fact that cervical cancer is now a largely preventable disease, a recent study showed that 31% of women in the Connaught/Ulster region (aged 25+) do not go for regular smear tests (at least one in the past 3 years).1 Although eight women died of the disease in this region last year,2 64% of local women (aged 25+) said that they did not consider themselves at risk of contracting cervical cancer.1   Speaking at the meeting entitled “Cervical Cancer – Prevention For All Women”, Clinical Midwife Specialist, Maura Molloy said, “All women have to ensure they are taking responsibility for their cervical health and start asking questions about cervical cancer. Every woman should know and understand what causes this disease and even more importantly how it can now be prevented. Many women still don’t understand that cervical cancer is for example not hereditary and why they may be at risk. Getting vaccinated and continuing to have regular smear tests is the most effective way of preventing cervical cancer so I would strongly urge women to make the time to talk to their GP or practice nurse about how they can best protect themselves.” A local GP also spoke to women at the meeting as did Susie Kola, an NUI Galway PHD student.   The meeting was supported by GlaxoSmithKline, who have been running an ongoing campaign to raise awareness about the disease and how it can be prevented by getting vaccinated as well as attending for regular smear tests at their local GP or health clinic.   In Europe, a woman dies from cervical cancer every 18 minutes3, while approximately 70 - 75 women in Ireland die from the disease every year4. Any woman, young or old, who is sexually active, is at risk of cervical cancer5. The 10/2007Cervarix1088 disease is caused by certain high risk types of the Human Papilloma Virus (HPV) which up to 80% of women will come into contact with at some point in their life6,7,8. HPV is a common virus which is transmitted through sexual intercourse, or intimate skin-to-skin genital contact9.   For more information log onto www.preventcervicalcancer.ie   - Ends –  For further information please contact: Claire Taaffe, Communications Manager, GSK. T : 01 4955218 / 086-8053251. E : claire.l.taaffe@gsk.com   Notes to Editors  About GSK GlaxoSmithKline- one of the world’s leading research-based pharmaceutical and healthcare companies-is committed to improving the quality of human life by enabling people to do more, feel better and live longer.   References 1. Research Solutions market research conducted on behalf of GSK, June 2006. 2. CSO preliminary figures on number of deaths due to cervical cancer in 2006 3. Ferlay J et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon 2004. 4. Women and Cancer in Ireland 1994-2001. National Cancer Registry Ireland. Published February 2006. 5. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol 2005; 32S: S16-S24. 6. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer – burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13. 7. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102 (5A): 3-8.  8. Brown DR, Shew ML, Qadadri B et al.  A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.  JID 2005; 191: 182-92 9. Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 2003; 31: 14-19.    

Anxiety and the Colposcopy Experience

Abstract

Similar works

Full text

Available Versions

University of Huddersfield Repository